Contract drug research in China is expanding

03/24/2013 | PharmaTimes (U.K.)

Contract research for the pharmaceutical industry in China reached $3.5 billion to $4.5 billion two years ago, according to a new report from Research and Markets. China should continue to grow as a market for contract research organizations as multinational firms look for venues with low costs, a skilled professional pool and a broad range of critical diseases and conditions to study.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ